Asthma is a complicated condition, one that has multiple causes, varying degrees of severity, and no cure. Therefore, treating asthma is a matter of managing it to ward off symptoms and prevent ...

It has been recommended for approval by the EMA’s human medicines committee – the CHMP – as a once-daily maintenance treatment for patients whose asthma can’t be controlled with two-drug ...

In recent years, the research progress of inhaler triple therapy (LABA + LAMA + ICS) as an essential treatment for COPD and asthma has attracted much attention. Similarly, there is a paucity of ...

However, you can also feel more congested when your asthma worsens or when you need adjustments in your asthma treatment. Chest congestion from asthma can cause symptoms like coughing, the need to ...

Rockville, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global triple combination therapy market reached a valuation of ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

Feldman, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily metered dose inhaler, ...

Asthma continues to be a prevalent chronic inflammatory disorder characterized by unpredictable exacerbations that severely affect the individual's quality of life, leading to significant healthcare ...

A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma ... some tumors disappearing completely with the triple MEKi-BETi-CDKi combination.

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

Specifically, Dupixent is approved to treat moderate to severe asthma that is either: dependent on treatment with an oral corticosteroid, or eosinophilic (caused by an increase in eosinophils ...